{"disease":{"id":"acute-on-chronic-hepatitis","name":"acute on chronic hepatitis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03577938","title":"Study on the Optimal Strategy for Acute-on-chronic Liver Failure With Integrative Treatment","phase":"NA","overall_status":"COMPLETED","enrollment_count":516,"lead_sponsor_name":"Beijing 302 Hospital","has_results":false},{"nct_id":"NCT06190002","title":"Characteristics and Risk Factors for Invasive Fungal Infection With Acute-on-chronic Hepatitis B Liver Failure","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Qilu Hospital of Shandong University","has_results":false},{"nct_id":"NCT03977857","title":"Prediction Model Based on Computed Tomography Liver Volume for the Short-term Mortality in Hepatitis B Related Acute-on-Chronic","phase":"","overall_status":"COMPLETED","enrollment_count":486,"lead_sponsor_name":"First Affiliated Hospital Xi'an Jiaotong University","has_results":false},{"nct_id":"NCT03534141","title":"Mild Hypothermia and Acute Kidney Injury in Liver Transplantation","phase":"NA","overall_status":"TERMINATED","enrollment_count":175,"lead_sponsor_name":"University of California, San Francisco","has_results":true},{"nct_id":"NCT05786859","title":"The Efficacy and Safety of Rifaximin Treatment","phase":"EARLY_PHASE1","overall_status":"UNKNOWN","enrollment_count":124,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT07275554","title":"Analysis of Methylomic Features and Prognostic Risk Prediction in Patients With Hepatitis B-related Acute-on-chronic Liver Failure","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Qilu Hospital of Shandong University","has_results":false},{"nct_id":"NCT06890039","title":"A-TANGO Phase 2 Study","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":78,"lead_sponsor_name":"Yaqrit Ltd","has_results":false},{"nct_id":"NCT04431375","title":"Efficacy of Addition of Fecal Microbiota Transplant (FMT) and Plasma Exchange to Tenofovir in Comparison to Monotherapy With Tenofovir in ACLF-HBV","phase":"NA","overall_status":"UNKNOWN","enrollment_count":70,"lead_sponsor_name":"Institute of Liver and Biliary Sciences, India","has_results":false},{"nct_id":"NCT06285253","title":"miroliverELAP® for the Treatment of Acute Liver Failure: A Phase 1 Trial","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Miromatrix Medical Inc.","has_results":false}],"total":9},"guidelines":[],"source":"Drug Landscape verified database"}